Press center

Welcome to the press center of MOLOGEN AG. On this page you find current press releases in German and English language, as well as multimedia in our mediathek, press photos, presentations, product charts, interesting reading material and much more. We also provide a press kit. Please contact us if you wish to receive a copy.

For questions and background information concerning our company please do not hesitate to contact us.

Prof. Peter W. Hübner
Head of Corporate Communications

The Paul-Ehrlich Institute has granted approval for a phase I clinical study of a gene therapy with MGN1404 for the treatment of melanomas. The study is entitled "Phase I trial of TNF-alpha expressing MIDGE-vector non-viral gene transfer in skin metastases of melanoma." The study will be conducted by collaborative partners Charité... [more]